RESEARCH-USE BIOSIMILAR ANTIBODY
Brodalumab
Monoclonal antibody · IgG2
Brodalumab (AMG 827) is a human anti-interleukin-17-receptor IgG2 monoclonal antibody that can be used for the research of moderate-to-severe plaque psoriasis and rheumatoid arthritis.
TARGETIL17RA
YMonoclonal antibody
CATALOGSC-BS-693
CATALOG NUMBERSC-BS-693
MOLECULAR WEIGHTApprox. 144.06 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Brodalumab (AMG 827) is a human anti-interleukin-17-receptor IgG2 monoclonal antibody that can be used for the research of moderate-to-severe plaque psoriasis and rheumatoid arthritis.
Brodalumab is a recombinant research-use antibody directed against IL17RA.